『Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovation』のカバーアート

Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovation

Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovation

著者: David Brühlmann - CMC Development Leader Biotech C-level Advisor Business Strategist
無料で聴く

このコンテンツについて

The Go-to Podcast for Biotech Scientists Who Want to Master Biopharma CMC Development and Biomanufacturing.

**TOP 10 LIFE SCIENCES PODCAST**

Are you ready to simplify bioprocess development and scale with confidence to reduce time to market?

Are you feeling overwhelmed by the complexity and guesswork of biologics development and biomanufacturing?

Do you wish you had more time to enjoy the beauty of science, without worrying about failing your cell culture process development and commercialization?

There's a way to simplify and streamline so you can remove complexity, skip trials and errors, deliver your groundbreaking therapy to clinics and market without delay, and still enjoy every single step.

I'm David Brühlmann, a biotech entrepreneur and strategic advisor who partners with C-level biopharma leaders to tackle one of our industry's biggest challenges: reducing manufacturing costs to make lifesaving therapies accessible to more patients worldwide.

Through engaging conversations with industry pioneers and practical insights from the trenches, this podcast tackles the critical challenges in bioprocess CMC development and manufacturing of recombinant proteins and cell and gene therapy products. We cut through the complexity so you can:

  • Master bioprocess development with confidence and clarity


  • Excel at scale-up and manufacturing of biologics


  • Transform your innovative therapy and manufacturing technology into market-ready solutions faster


  • Optimize manufacturing costs without compromising quality


  • Make data-driven decisions that reduce the risk of failure


I can’t wait to help you do biotech the smart way.

Grab a cup of coffee and your favorite notebook and pen. Now is the time to take your bioprocessing game to the next level.

Ready to transform your biomanufacturing journey? Let's dive in!

Next Steps:

Book a free call to reduce biomanufacturing costs and make lifesaving therapies more accessible: https://bruehlmann-consulting.com/call

Fast-track bioprocess development with expert guidance: https://bruehlmann-consulting.com

Visit the Website: https://smartbiotechscientist.com

Email us: hello@bruehlmann-consulting.com

© 2025 Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovation
生物科学 科学
エピソード
  • 168: How Generative AI Is Revolutionizing Biotech Regulatory Compliance with Abhijeet Satwekar - Part 2
    2025/07/03

    The promise of generative AI in pharma and biotech is huge, but it's also fraught with complexity, especially when it comes to integrating these systems into highly regulated environments. From monitoring evolving guidelines to balancing operational efficiency and data integrity, the journey from hype to real-world impact is filled with both opportunity and skepticism.

    In this episode, David Brühlmann sits down with Abhijeet Satwekar, Innovation Manager at Merck Healthcare’s Global Analytical Development. Abhijeet has spent years on the front lines of digital transformation in the biotech sector, and his current mission: implementing generative AI for regulatory guideline monitoring, without giving the quality team a collective heart attack. He offers a no-nonsense roadmap for biotech leaders looking to streamline compliance, harness AI potential, and future-proof their operations.

    Here are three reasons you should hit play on this episode:

    • From Proof of Concept to Real-World Implementation: Discover how Abhijeet’s team moved beyond early excitement to tackle regulatory, IT, and data privacy requirements, carving a safe and compliant path for bringing generative AI tools into GxP and GMP-adjacent workflows.
    • Human-in-the-Loop Isn’t Optional: Learn why user training, prompt engineering, and close collaboration between scientists and AI are essential for extracting meaningful (and accurate) insights, especially in environments where routine and regulation reign supreme.
    • ROI and Regulation - The Balancing Act: Hear candid perspectives on measuring the return on investment for new digital tools, addressing skeptics closer to manufacturing, and why the real game-changer might just be a community-driven, industry-wide approach to regulatory acceptance.

    Wondering how to unlock GenAI’s full potential - or just avoid the common pitfalls? Dive into this episode for practical strategies, cautionary tales, and actionable insights from someone who’s actually navigated the compliance minefield.

    Bring AI into your pipeline with confidence, clarity, and compliance.

    Connect with Abhijeet Satwekar:

    LinkedIn: https://www.linkedin.com/in/abhijeetsatwekar

    Next step:

    Book a free consultation to help you get started on any questions you may have about bioprocessing development: https://bruehlmann-consulting.com/call

    Develop bioprocessing technologies better, faster, at a fraction of the cost with our 1:1 Strategy Call: The quickest and easiest way to excel biotech technology development. Book your call at https://stan.store/SmartBiotech

    Support the show

    続きを読む 一部表示
    25 分
  • 166: Why Your Funding Pitches Fail Despite Brilliant Science (And How to Fix It) - Part 2
    2025/06/26

    Have you ever presented a major scientific breakthrough, only to be met with blank stares and distracted executives? You're not alone. In this episode, David Brühlmann shares how he went from drowning in data to winning an innovation contest, not through better tech, but through the power of scientific storytelling.

    Many scientists default to methods and data, but as David notes, “it’s like being fluent in a language nobody else in the room speaks.” Without a clear link to human impact, even the most brilliant work can go unnoticed.

    Key insights from the episode that could transform your next presentation:

    • The Three-Act Structure: Storytelling That Resonates - David shows how Apple’s iPhone launch used this classic structure, and how scientists can do the same. Start with “why” (impact), then move to “how” (the science) to keep your audience engaged without losing rigor.
    • Turning Your Audience Into the Hero: Adapting Donald Miller’s framework, David flips the script: your audience is the hero, and your innovation is their guide. It’s about speaking to their needs, not just showcasing your work.
    • Why Storytelling Works: The Neuroscience Edge: Stories release dopamine (focus), oxytocin (trust), and endorphins (emotion) - activating how we naturally learn and remember. It’s not fluff; it’s brain science.

    Decision-makers won’t remember your chromatogram, but they will remember the story and its impact. The real test of your pitch? Whether it drives action: follow-up meetings or funding.

    You don’t need to simplify your science. You need to spotlight what matters most to your audience. With a strong narrative, your work stops being overlooked potential and starts becoming real-world impact.

    Ready to revolutionize your next presentation? Lean into the power of storytelling - your data, your career, and the lives you touch will thank you.

    Listen to the full episode to explore the straightforward storytelling structure David uses to bring scientific ideas to life.

    🔗 Book a free 20-minute consultation with Brühlmann Consulting to answer any questions you may have about how to craft a compelling scientific story that connects and inspires. https://bruehlmann-consulting.com/call/

    🔗 Turn Your Science into Funding Success. Book a 30-minute strategy session to transform your technical pitch into a compelling story that gets funded. Limited spots available. Schedule now at https://stan.store/SmartBiotech/p/turn-science-into-funding-a-pitch-that-sells

    Support the show

    続きを読む 一部表示
    17 分

Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovationに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。